A new survey by researchers at the U-M Rogel Cancer Center and Institute for Healthcare Policy and Innovation suggests many patients are receiving the treatment when there’s no strong indication of benefit.
U-M Rogel Cancer Center and College of Engineering researchers found breast cancer cells that swallow up nearby stem cells, making it easier for them to invade other tissues and seed secondary tumors.